Kadena KDA Scaled POW - 1st in the World!! 480K TPS(20chains)From 10 chains to 20 chains, Kadena is now able to achieve 480K Transactions per second on 20 chains.
This is their first successful mainnet fork, first ever in the world when nobody said Bitcoin could scale.
Kadena can keep scaling with no limits to 1000 and over chains..this means millions of TPS at least.
No blockchain has ever successfully scaled POW except for Kadena!
Kadena is built by JP Morgan elites.
They have worked with the SEC, JP Morgan, Financial Institutions in the past. the power of Kadena means that Huge enterprises will flock in because Kadena can now accept Enterprise usage. AWS and Azure is up for KDA already.
#DeFi partnership, U.S. Exchange listing(Q3-Q4), Rosetta Coinbase integration is ALL coming in September.. there is also an update coming from USCF investments.
Kadena is only 20mil + in market cap now. such a small cap with huge potentials will be rocketing in this bull market.
Many influencers are starting to notice this GEM.. Take note
Now for the price, i feel this gem can easily go above 300mil, even more than 1billion in Market cap.
this Gem is only less than 30 mil now as it has not yet hit Tier 1 Exchanges. Coinbase is already looking to list it.
Rosetta
Big rectangle Rose Garden or Bear Flag?$ROSE is lower after earnings. Looking at the weekly chart it is range bound in this big rectangle. 16$ is support from lows in late January and mid March. 16$ can be a short targets because of it's snap back rallies to the top of the range. The top is only two weekly bars from the January low and it was above 25$
The breakdown below 32$ in November of last year makes it look like a pole on a bear flag. Or a range bound rectangle rose garden. Or bear's big brown foot. Perspective is in the eye of the beholder.
Small Biotech Out Of Favor But Smart Buys Can Pay OffThe deep freeze has taken over small cap land. It has been a long time since small caps were out of vogue but the time has come. As the great rotation of capital shifts from high risk stocks to low risk, high dividend payers, many think the end has come for any investments in small caps. I am here to say that is not true. Over the past year, you could have closed your eyes and thrown a dart at a small cap and made a lot of money. Those times have changed, however there is still money to be made.
You must now start analyzing the charts and buy at the key levels. For example, on no news, Rosetta Genomics Ltd. (NASDAQ:ROSG) has fallen from over $6.50 to $3.45. This monster drop is now crossing the 200 moving average and heading to gap fill at $3.20. This $3.20 level will be where the stock price has been cut in half as well as major support. At this discount, the stock becomes extremely attractive to tuck away a small position.
Another biotech stock approaching a key level is OXiGENE Inc (NASDAQ:OXGN). Good news drove it to $5.40, however the risk adverse market has taken it down to $2.59. There is a key gap fill at $2.43 that offers a very intriguing risk to reward opportunity.
Always remember small cap stocks are very high risk. Most likely the way to trade these plays is to be in, get a solid bounce and take profits.
Gareth Soloway
Chief Market Strategist
www.InTheMoneyStocks.com
